Overview
Fatty liver disease is a condition characterised by the accumulation of excess fat within liver cells, which can provoke inflammation and progressive liver damage. It includes alcohol-related forms driven by excessive alcohol consumption and non-alcoholic forms associated with obesity, type 2 diabetes, metabolic disturbance, and certain medications, and if untreated it can advance to steatohepatitis, fibrosis, and cirrhosis. The topic is clinically significant because fatty liver disease is among the most common chronic liver conditions worldwide, often progresses silently, and is closely tied to metabolic and nutritional health, making early diagnosis and lifestyle intervention important. Research published in this area examines the epidemiology of chronic liver disease through retrospective hospital-based studies in Ethiopia, the genetics of hepatic steatosis, including single nucleotide polymorphisms linked to alimentary fatty liver disease and to treatment-associated steatosis in HIV patients on antiretroviral therapy, and biomarkers of liver injury and angiogenesis in hepatocellular carcinoma complicating hepatitis C. Nutritional and metabolic dimensions feature prominently, with studies on vitamin D deficiency in chronic liver disease, epigenetics and nutrition, the glycemic index of a liver nutritional supplement, probiotic anti-inflammatory activity in fermented foods, and thyroid hormone contributions in obesity. Additional work addresses non-invasive assessment of liver stiffness and molecular biology relevant to liver pathology, reflecting an integrative view of liver health.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Single Nucleotide Polymorphisms associated with alimentary fatty liver disease are not genetic risk factors for treatment-associated hepatic steatosis in HIV patients on HAART
Liver Disease: A Retrospective Hospital Based Study in Addis Ababa-Ethiopia
Epigenetics and Nutrition
Developing Cellular & Molecular Biomarkers for Anti-Inflammatory Activities of Probiotic Bacteria in Fermented Foods
Liver Stiffness by ARFI does not Correlate with Decompensation and Portal Hypertension in Patients with Cirrhosis
RBM45: Molecular, Cellular, and Evolutionary Biology
Evaluation of Vitamin D Deficiency in Patients with Chronic Liver Disease and Its Clinical Significance
Estimation of Glycemic Index of Liver Nutritional Supplement and its Importance in Liver Nutrition
Adaptive Contribution of Thyroid Hormones in Obesity
Role of Tie2, CD14, Angiopoietin as Angiogenetic Markers in Hepatocellular Carcinoma Complicating Hepatitis C Virus Infection
How this research is being cited
The 12 articles above have been cited 37 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Biochemical Pharmacology
-
2026 · Alcohol and Alcoholism
-
2026 · BioMed Research International
-
Hami Hemati et al. · 2025 · Brain, behavior, and immunity
-
2025 · Deleted Journal
-
2025 · BMC Gastroenterology
-
2025 · BMC Gastroenterology
-
Harriet Chinwe Nwadimkpa et al. · 2025 · Discover medicine
A sample of recent works citing this journal's research on Fatty Liver Disease, linking to each citing work.